36 min listen
ACT #283 Susan Lin, Partner & Investor at Felix Capital on consumer investing
FromEUVC
ratings:
Length:
34 minutes
Released:
Feb 24, 2024
Format:
Podcast episode
Description
Welcome to a new episode of our special series At The Cap Table.Today, we are joined by Sarah Finegan, an Investor at Antler, in a conversation with Susan Lin, a Partner & Investor at Felix Capital.Susan is an investor at Felix Capital. Over the past 10+ years, Susan has advised, invested, and worked in a range of consumer and technology companies in their journeys to grow and scale. Susan joined Felix Capital from HgCapital, a London-based private equity fund where she focused on software investments and portfolio companies. Prior to HgCapital, Susan was a management consultant at Bain & Company in San Francisco, Singapore, and London, advising private equity and growth capital funds on potential investments and CPG and e-commerce companies on go-to-market, M&A, and growth strategies.Felix Capital is a venture capital firm for the creative class, operating at the intersection of technology and creativity. The fund focuses on digital lifestyle across multiple verticals, investing in authentic consumer-facing brands and platforms and related enabling B2B technologies. Their mission is to be a partner of choice for entrepreneurs with big ideas and help them build category-defining companies that move the world forward.Chapters:00:00:00 Introduction and Welcome00:02:16 Susan's Journey into Venture Capital00:02:51 The Impact of Parents' Entrepreneurship00:04:31 Susan's Career Path and Experiences00:05:34 Transition into Investing and Joining Felix Capital00:06:54 Understanding Felix Capital and Its Approach00:12:44 Opportunities in Consumer Investing00:18:22 Impact and Positive Change in Investments00:20:47 Outlook on Investing and Advice for Founders00:26:10 Diversity in Europe's Tech Ecosystem00:29:35 Advice to Younger Self and Conclusion
Released:
Feb 24, 2024
Format:
Podcast episode
Titles in the series (100)
#1 Marc Lohrmann, Vesalius Biocapital: Episode 1 features Marc Lohrmann, Managing Partner of Vesalius Biocapital III, a 120 €M venture capital fund investing in late-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, across all of Europe. Prior to... by EUVC